Terbinafine effectiveness in ketoconazole-resistant mucocutaneous candidasis in polyglandular autoimmune syndrome type 1.
Hassan
G
G
D000935:Antifungal Agents / Q000627:therapeutic use*; D002178:Candidiasis, Chronic Mucocutaneous / Q000188:drug therapy* / Q000209:etiology*; D025141:Drug Resistance, Fungal; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use*; D009281:Naphthalenes / Q000627:therapeutic use*; D016884:Polyendocrinopathies, Autoimmune / Q000150:complications* / Q000188:drug therapy*; D000077291:Terbinafine; D016896:Treatment Outcome
D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine; D007654:Ketoconazole